A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets

Figure 3

The comparation of neoantigens between different subgroups and cohorts: (a) between age ≧60 and age <60 groups; (b) between female and male groups; (c) between different stages; (d) between different locations; (e) between different Lauren types; (f) between different cohorts.

(a)

(b)

(c)

(d)

(e)

(f)